|

SCIENCE NEWS
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Pluristem Therapeutics Inc. today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia, the end-stage of peripheral artery disease. [Pluristem Therapeutics Inc, Haifa]
Green Tea Component may Help Preserve Stored Platelets, Tissues
In two separate studies, a major component in green tea, epigallocatechin-3-O-gallate (EGCG), has been found to help prolong the preservation of both stored blood platelets and cryopreserved skin tissues. [Institute for Frontier Medical Sciences, Kyoto]
Blood Vessels Contribute to Their Own Growth and Oxygen Delivery to Tissues and Tumors
The findings, published in the Sept. 15 issue of the journal Developmental Cell, could give important insights into the formation of the vasculature needed to feed new tumors. [University of North Carolina, Chapel Hill]

|
|
|
EVENTS
51st ASH Annual Meeting and Exposition December 9-12, 2009 New Orleans, LA
2010 BMT Tandem Meetings February 24-28, 2010 Orlando, Florida
The European Group for Blood & Marrow Transplantation Annual Meeting March 21-24, 2010 Vienna, Austria
Canadian Blood and Marrow Transplant Consortium Annual Meeting April 7-10, 2010 Vancouver, BC
16th Annual International Society for Cellular Therapy Meeting May 22-26, 2010 Philadelphia, Pennsylvania
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
Have we missed an important article or publication in Cord Blood News? Click here to submit!
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|